SGNI OTC
StemGen, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -96.0%
5Y: -87.5%
$0.10
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$39K
+101.6% ▲
Gross Profit
$9K
-20.7% ▼
Operating Income
-$244K
-263.8% ▼
Net Income
-$433K
-87.6% ▼
EPS (Diluted)
$-0.01
-15.9% ▼
EBITDA
-$180K
-277.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $22K | $19K | $39K |
| YoY Growth | +0.0% | +0.0% | +0.0% | -12.3% | +101.6% |
| Cost of Revenue | $0 | $0 | $9K | $9K | $30K |
| Gross Profit | $0 | $0 | $14K | $11K | $9K |
| Gross Margin | — | — | 61.4% | 55.7% | 21.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $32K | $197K | $58K | $140K |
| Operating Expenses | $8K | $32K | $257K | $78K | $252K |
| Operating Income | $8K | -$32K | -$243K | -$67K | -$244K |
| Operating Margin | — | — | -1101.6% | -346.6% | -625.6% |
| Interest Expense | $78K | $92K | $57K | $141K | $141K |
| Income Before Tax | -$70K | $6K | -$426K | -$231K | -$433K |
| Tax Expense | -$2 | $0 | $0 | $0 | $0 |
| Net Income | -$70K | $6K | -$426K | -$231K | -$433K |
| Net Margin | — | — | -1931.3% | -1192.6% | -1110.3% |
| EPS (Diluted) | $-0.01 | $0.00 | $-0.02 | $-0.01 | $-0.01 |
| EBITDA | $8K | $98K | -$308K | -$71K | -$180K |
| Shares Outstanding | 14M | 14M | 24M | 45M | 46M |